Phosphatase PTEN in neuronal injury and brain disorders

Ning Chang1, Youssef H El-Hayek, Everlyne Gomez

  • 1Division of Fundamental Neurobiology, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada.

Trends in Neurosciences
|October 26, 2007
PubMed

Insights

Phosphatase and tensin homologue (PTEN) is a tumor suppressor. Beyond cancer, PTEN is vital in neuronal injury and various brain disorders, offering new therapeutic targets for CNS diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Oncology

Background:

  • Phosphatase and tensin homologue (PTEN) is a known tumor suppressor.
  • PTEN inactivation is linked to glioblastoma pathogenesis in the central nervous system (CNS).
  • Emerging evidence suggests PTEN's involvement in non-cancerous brain diseases.

Purpose of the Study:

  • To review the role of PTEN in neuronal injury and CNS disorders.
  • To explore PTEN's potential as a therapeutic target for neurological and psychiatric conditions.

Main Methods:

  • Literature review of studies on PTEN in CNS pathophysiology.
  • Analysis of PTEN's involvement in neuronal injury models.
  • Examination of PTEN's role in neurological and psychiatric disease mechanisms.

Main Results:

  • PTEN plays a critical role in neuronal injury.
  • PTEN is implicated in a range of neurological and psychiatric disorders beyond cancer.
  • Evidence supports PTEN's broader function in CNS health and disease.

Conclusions:

  • PTEN has a significant role in CNS pathophysiology, extending beyond its tumor-suppressive function.
  • PTEN represents a promising molecular target for novel therapeutic strategies in CNS diseases.
  • Further research into PTEN's multifaceted roles could lead to innovative treatments for brain disorders.

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphorylation01:02

Phosphorylation

The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...